Hopstem Biotechnology Inc. (hereinafter referred to as "Hopstem"), a company dedicated to the development of induced ...

A stroke patient at HonorHealth Research Institute is the first in Arizona to receive a new investigational treatment that ...

New nanomaterial passes the blood-brain barrier to reduce damaging inflammation after the most common form of stroke. When ...

Early dual antiplatelet therapy shows superior efficacy in reducing stroke recurrence compared with aspirin monotherapy.

The registry data suggest improved outcomes without safety concerns, but confirmatory RCTs are needed, a researcher says.

Pregnant patients with prior ischemic stroke had significantly higher odds of ischemic stroke during pregnancy and the ...

"Given the widespread use of these products and the severity of arterial thrombotic events, the findings have important public health implications," the authors write. HealthDay News — Contemporary ...

A new blood marker reflects the extent of brain injury after an ischemic stroke and can predict patient outcomes months to ...

Introduction: Atrial fibrillation (AF) is a major risk factor for ischemic stroke (IS). Its diagnosis can be challenging, ...

A new University of Manchester and Edinburgh study published in the journal Brain, Behavior and Immunity has found that ...

A metric for acute stroke care failed to identify preventable events in those patients requiring endovascular thrombectomy ...